UPI Share Price

Open 1.26 Change Price %
High 1.29 1 Day -0.03 -2.40
Low 1.18 1 Week 0.00 0.00
Close 1.22 1 Month 0.00 0.00
Volume 236637 1 Year 0.00 0.00
52 Week High 2.88
52 Week Low 0.35
UPI Important Levels
Resistance 2 1.32
Resistance 1 1.28
Pivot 1.23
Support 1 1.16
Support 2 1.12
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Uroplasty, Inc. (NASDAQ: UPI)

UPI Technical Analysis 5
As on 31st Mar 2015 UPI Share Price closed @ 1.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.30 & Strong Sell for SHORT-TERM with Stoploss of 1.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
UPI Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
UPI Other Details
Segment EQ
Market Capital 73255040.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.uroplasty.com
UPI Address
UPI
5420 Feltl Road
Minnetonka, MN 55343
United States
Phone: 952-426-6140
Fax: 952-426-6199
UPI Latest News
How Reimbursement-Savvy Sales Personnel Increase A Company's Bottom Line   Med Device Online (press release)   - 06th Dec 16
Uroplasty and Vision-Sciences Complete Merger   PR Newswire (press release)   - 01st Apr 15
Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement   PR Newswire (press release)   - 30th Mar 15
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve ...   PR Newswire (press release)   - 24th Feb 15
Medtronic buys device to treat bladder-control issues   Minneapolis Star Tribune   - 24th Feb 15
Uroplasty and Vision-Sciences to Merge, Creating Medical Device Company ...   PR Newswire (press release)   - 22nd Dec 14
AMS exec jumps to Uroplasty   Minneapolis / St. Paul Business Journal   - 10th Dec 13
Uroplasty Provides Update On PTNS Reimbursement   PR Newswire (press release)   - 04th Dec 13
Uroplasty CEO Resigns; Ex-MN Med-Tech Leader Steps In   Twin Cities Business Magazine   - 09th Apr 13
Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement ...   PR Newswire (press release)   - 03rd Nov 10
Interactive Technical Analysis Chart Uroplasty, Inc. ( UPI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Uroplasty, Inc.
UPI Business Profile
Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company�s primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-approved minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique Implants a urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency (ISD). Outside of the United States, the Company�s Urgent PC is also approved for treatment of fecal incontinence, and Macroplastique is also approved for treatment of male stress incontinence and vesicoureteral reflux.